Abstract 4745: Precision cancer medicine program for whole-exome sequencing of metastatic tumors reveals biomarkers of response
Himisha Beltran(Dana-Farber Cancer Institute), Mark A. Rubin(University of Bern), Myriam Kossaï(Inserm), Kenneth Eng(Cornell University), David M. Nanus(Cornell University), David S. Rickman(Cornell University), Jenny Xiang(Cornell University), Chantal Pauli(University of Zurich), Bishoy M. Faltas(Cornell University), Hanna Rennart(Cornell University), Alessandro Romanel(University of Trento), Juan Miguel Mosquera(NewYork–Presbyterian Hospital), Andrea Sboner(Cornell University), Brian D. Robinson(Cornell University), Olivier Elemento(Cornell University), Francesca Demichelis(University of Trento), Alexandros Sigaras(NewYork–Presbyterian Hospital), Jacqueline Fontugne(Centre National de la Recherche Scientifique), Scott T. Tagawa(Cornell University)
Cited by 1
Related Papers
The landscape of somatic copy-number alteration across human cancers
|Nature|2010|4.1k
Integrative Clinical Genomics of Advanced Prostate Cancer
|Cell|2015|3.6k
Pancreatic cancer exosomes initiate pre-metastatic niche formation in the liver
|Nature Cell Biology|2015|2.7k
DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer
|New England Journal of Medicine|2015|2.2k
Ferroptosis is an autophagic cell death process
|Cell Research|2016|1.9k